Evidence map›Paper›PMID 32990789›Full record

ArticleDer Nervenarzt2020

[Brivaracetam-A good alternative for the treatment of muscle cramps].

Katharina Kneppe, David Czell

Abstract read
PubMed Publisher
In one paragraph

Article in Der Nervenarzt, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Katharina KneppeDepartment of Medicine, Neurology, Spital Linth, Uznach, Schweiz.
David CzellDepartment of Medicine, Neurology, Spital Linth, Uznach, Schweiz. david.czell@hin.ch.
Spital Linth · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMuscle cramps are suddenly occurring involuntary, mostly painful contractions of a single muscle, rarely of a muscle group. They can be idiopathic or occur in various neuromuscular diseases and can sometimes substantially impair the quality of life due to the frequency and strength. Only a few drugs are available for the effective treatment of cramps.

resultsIn this case series we report on five patients with cramps of different origin who responded well to treatment with brivaracetam. DISCUSSION: Brivaracetam is actually used for the treatment of epileptic seizures. It binds to the synaptic vesicle protein 2A (SV2A), which also occurs in nerves and nerve roots. The SV2A regulates the exocytotic release of neurotransmitters, which could explain the effect of brivaracetam on muscle cramps.

conclusionFurther studies are needed to demonstrate the effect of brivaracetam on muscle cramps.

Indexed as

Muscle CrampQuality of LifeAnticonvulsantsHumansPyrrolidinonesAnticonvulsantsbrivaracetamPyrrolidinonesBrivaracetamLevetiracetamMuscle crampsNeuromuscular diseaseVesicle protein 2A

Identifiers

PMID32990789
OpenAlexW3091445796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.